May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Monokine Induced by Interferon (Mig) (CXCL9) in the Vitreous of Patients With Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • T. Tsuboi
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
    Ophthalmology, Tokyo Medical University Hachioji Medical Center, Tatemachi 1163, Hachioji-Shi, Tokyo, Japan
  • Y. Usui
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
    Ophthalmology, Tokyo Medical University Hachioji Medical Center, Tatemachi 1163, Hachioji-Shi, Tokyo, Japan
  • Y. Okunuki
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • M. Takeuchi
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • H. Minoda
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • T. Hattori
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • T. Iwasaki
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • H. Goto
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • M. Usui
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
  • Y. Wakabayashi
    Ophthalmology, Tokyo Medical University Hospital, Shinjuku-Ku, Japan
    Ophthalmology, Tokyo Medical University Hachioji Medical Center, Tatemachi 1163, Hachioji-Shi, Tokyo, Japan
  • Footnotes
    Commercial Relationships T. Tsuboi, None; Y. Usui, None; Y. Okunuki, None; M. Takeuchi, None; H. Minoda, None; T. Hattori, None; T. Iwasaki, None; H. Goto, None; M. Usui, None; Y. Wakabayashi, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4961. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Tsuboi, Y. Usui, Y. Okunuki, M. Takeuchi, H. Minoda, T. Hattori, T. Iwasaki, H. Goto, M. Usui, Y. Wakabayashi; Monokine Induced by Interferon (Mig) (CXCL9) in the Vitreous of Patients With Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4961.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To determine the intra-vitreous levels of human monokine induced by interferonγ(Mig)(CXCL9) in patients with proliferative diabetic retinopathy (PDR). In addition, the relationship between the concentration of Mig and PDR activity has also been evaluated.

Methods:: Vitreous samples were collected at the time of vitreoretinal surgery from 17 eyes of PDR patients and from 11 eyes of nondiabetic patients (control subjects) who had macular hole and epiretinal membrane (6 and 5 eyes, respectively). Stages of PDR were classified as active or quiescent. Concentrations of Mig and vascular endothelial growth factor (VEGF) in vitreous fluid were simultaneously measured by cytometric bead array using flow cytometer.

Results:: Intravitreous concentrations of Mig were significantly higher in PDR (4897.5 pg/ml) than in control patients (17.2 pg/ml) (p<0.001). Intravitreous concentrations of VEGF were also higher in PDR (945.2pg/ml)than in control patients(8.8pg/ml)(p<0.001). The vitreous fluid level of Mig weas significantly correlated with that of VEGF (p<0.001).

Conclusions:: We found that level of Mig in vitreous fluid of PDR patients are significantly higher than in nondiabetic patients and that the levels of Mig are elevated in the active PDR stage. These findings suggest that Mig contributes to the development and progression of PDR in combination with VEGF.

Keywords: diabetic retinopathy • cytokines/chemokines • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×